(Q72112429)
Statements
Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer (English)
A Lipton
L M Demers
H A Harvey
K B Kambic
H Grossberg
C Brady
H Adlercruetz
P F Trunet
1 April 1995